188 related articles for article (PubMed ID: 37321378)
1. CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas.
Huang Q; Wu J; Le N; Shen Y; Guo P; Schreck KC; Kamson D; Blair L; Heo HY; Li X; Li W; Sair HL; Blakeley JO; Laterra J; Holdhoff M; Grossman SA; Mukherjee D; Bettegowda C; van Zijl P; Zhou J; Jiang S
Magn Reson Imaging; 2023 Oct; 102():222-228. PubMed ID: 37321378
[TBL] [Abstract][Full Text] [Related]
2. Amide proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas.
Wu M; Jiang T; Guo M; Duan Y; Zhuo Z; Weng J; Xie C; Sun J; Li J; Cheng D; Liu X; Du J; Zhang X; Zhang Y; Liu Y
Eur Radiol; 2024 May; 34(5):2986-2996. PubMed ID: 37855851
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T.
Liu J; Li C; Chen Y; Lv X; Lv Y; Zhou J; Xi S; Dou W; Qian L; Zheng H; Wu Y; Chen Z
J Magn Reson Imaging; 2020 Apr; 51(4):1154-1161. PubMed ID: 31430008
[TBL] [Abstract][Full Text] [Related]
4. Radiomics analysis of amide proton transfer-weighted and structural MR images for treatment response assessment in malignant gliomas.
Jiang S; Guo P; Heo HY; Zhang Y; Wu J; Jin Y; Laterra J; Eberhart CG; Lim M; Blakeley JO
NMR Biomed; 2023 Jan; 36(1):e4824. PubMed ID: 36057449
[TBL] [Abstract][Full Text] [Related]
5. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
[TBL] [Abstract][Full Text] [Related]
6. Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients.
Guo P; Unberath M; Heo HY; Eberhart CG; Lim M; Blakeley JO; Jiang S
Neuroimage Clin; 2022; 35():103121. PubMed ID: 35905666
[TBL] [Abstract][Full Text] [Related]
7. Predicting O6-Methylguanine-DNA Methyltransferase Protein Expression in Primary Low- and High-Grade Gliomas Using Certain Qualitative Characteristics of Amide Proton Transfer-Weighted Magnetic Resonance Imaging.
Su L; Gao P; Lin S; Wu B; Qin W; Lin Y; Xue J
World Neurosurg; 2018 Aug; 116():e814-e823. PubMed ID: 29803064
[TBL] [Abstract][Full Text] [Related]
8. Fully automated analysis combining [
Paprottka KJ; Kleiner S; Preibisch C; Kofler F; Schmidt-Graf F; Delbridge C; Bernhardt D; Combs SE; Gempt J; Meyer B; Zimmer C; Menze BH; Yakushev I; Kirschke JS; Wiestler B
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4445-4455. PubMed ID: 34173008
[TBL] [Abstract][Full Text] [Related]
9. Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis.
Suh CH; Park JE; Jung SC; Choi CG; Kim SJ; Kim HS
Neuroradiology; 2019 May; 61(5):525-534. PubMed ID: 30666352
[TBL] [Abstract][Full Text] [Related]
10. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
[TBL] [Abstract][Full Text] [Related]
11. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
[TBL] [Abstract][Full Text] [Related]
12. Whole-tumor amide proton transfer-weighted imaging histogram analysis to predict pathological extramural venous invasion in rectal adenocarcinoma: a preliminary study.
Chen W; Liu G; Chen J; Wei Q; Ye Y; Du X; Feng J; Yan Z; Deng K; Liu X
Eur Radiol; 2023 Jul; 33(7):5159-5171. PubMed ID: 36700956
[TBL] [Abstract][Full Text] [Related]
13. Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
Schön S; Cabello J; Liesche-Starnecker F; Molina-Romero M; Eichinger P; Metz M; Karimov I; Preibisch C; Keupp J; Hock A; Meyer B; Weber W; Zimmer C; Pyka T; Yakushev I; Gempt J; Wiestler B
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1468-1475. PubMed ID: 31953672
[TBL] [Abstract][Full Text] [Related]
14. Combining amide proton transfer-weighted and arterial spin labeling imaging to differentiate solitary brain metastases from glioblastomas.
Chen L; Li T; Li Y; Zhang J; Li S; Zhu L; Qin J; Tang L; Zeng Z
Magn Reson Imaging; 2023 Oct; 102():96-102. PubMed ID: 37172748
[TBL] [Abstract][Full Text] [Related]
15. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.
Zou T; Yu H; Jiang C; Wang X; Jiang S; Rui Q; Mei Y; Zhou J; Wen Z
NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29098732
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of true progression from treatment response in high-grade glioma treated with chemoradiation: a comparison study of 3D-APTW and 3D-PcASL imaging and DWI.
Hou H; Diao Y; Yu J; Xu M; Wang L; Li Z; Song T; Liu Y; Yuan Z
NMR Biomed; 2023 Jan; 36(1):e4821. PubMed ID: 36031734
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
Durmo F; Rydhög A; Testud F; Lätt J; Schmitt B; Rydelius A; Englund E; Bengzon J; van Zijl P; Knutsson L; Sundgren PC
PLoS One; 2020; 15(12):e0244003. PubMed ID: 33373375
[TBL] [Abstract][Full Text] [Related]
19. Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T.
Friismose AI; Markovic L; Nguyen N; Gerke O; Schulz MK; Mussmann BR
Radiography (Lond); 2022 Feb; 28(1):95-101. PubMed ID: 34509365
[TBL] [Abstract][Full Text] [Related]
20. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]